{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:34:36Z","timestamp":1783463676820,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,4,20]],"date-time":"2010-04-20T00:00:00Z","timestamp":1271721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1038\/nrclinonc.2010.40","type":"journal-article","created":{"date-parts":[[2010,4,20]],"date-time":"2010-04-20T10:13:42Z","timestamp":1271758422000},"page":"415-420","source":"Crossref","is-referenced-by-count":71,"title":["Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis"],"prefix":"10.1038","volume":"7","author":[{"given":"Matthew P.","family":"Strout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Seropian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Berliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,20]]},"reference":[{"key":"BFnrclinonc201040_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter, J. I.  et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 48, 124\u2013131 (2007).","journal-title":"Pediatr. Blood Cancer"},{"key":"BFnrclinonc201040_CR2","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","volume":"100","author":"JI Henter","year":"2002","unstructured":"Henter, J. I.  et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100, 2367\u20132373 (2002).","journal-title":"Blood"},{"key":"BFnrclinonc201040_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/MOH.0b013e3282f97f88","volume":"15","author":"RJ Arceci","year":"2008","unstructured":"Arceci, R. J. When T cells and macrophages do not talk: the hemophagocytic syndromes. Curr. Opin. Hematol. 15, 359\u2013367 (2008).","journal-title":"Curr. Opin. Hematol."},{"issue":"1","key":"BFnrclinonc201040_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1182\/asheducation-2009.1.127","volume":"2009","author":"A. H. Filipovich","year":"2009","unstructured":"Filipovich, A. H. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am. Soc. Hematol. Educ. Program 127\u2013131 (2009).","journal-title":"Hematology"},{"key":"BFnrclinonc201040_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00431-006-0258-1","volume":"166","author":"GE Janka","year":"2007","unstructured":"Janka, G. E. Familial and acquired hemophagocytic lymphohistiocytosis. Eur. J. Pediatr. 166, 95\u2013109 (2007).","journal-title":"Eur. J. Pediatr."},{"key":"BFnrclinonc201040_CR6","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1046\/j.1365-2141.2000.01923.x","volume":"108","author":"E Grunebaum","year":"2000","unstructured":"Grunebaum, E., Zhang, J., Dadi, H. & Roifman, C. M. Hemophagocytic lymphohistiocytosis in X-linked severe combined immunodeficiency. Br. J. Hematol. 108, 834\u2013837 (2000).","journal-title":"Br. J. Hematol."},{"key":"BFnrclinonc201040_CR7","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1084\/jem.151.5.1039","volume":"151","author":"T Haliotis","year":"1980","unstructured":"Haliotis, T.  et al. Chediak\u2013Higashi gene in humans. I. Impairment of natural-killer function. J. Exp. Med. 151, 1039\u20131048 (1980).","journal-title":"J. Exp. Med."},{"key":"BFnrclinonc201040_CR8","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","volume":"286","author":"SE Stepp","year":"1999","unstructured":"Stepp, S. E.  et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286, 1957\u20131959 (1999).","journal-title":"Science"},{"key":"BFnrclinonc201040_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","volume":"115","author":"J Feldmann","year":"2003","unstructured":"Feldmann, J.  et al. Munc13\u201314 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 115, 461\u2013473 (2003).","journal-title":"Cell"},{"key":"BFnrclinonc201040_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/humu.20274","volume":"27","author":"U Zur Stadt","year":"2006","unstructured":"Zur Stadt, U.  et al. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Hum. Mutat. 27, 62\u201368 (2006).","journal-title":"Hum. Mutat."},{"key":"BFnrclinonc201040_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00277-007-0324-4","volume":"86","author":"C Busemann","year":"2007","unstructured":"Busemann, C.  et al. Erdheim\u2013Chester disease with hemophagocytosis. Ann. Hematol. 86, 847\u2013849 (2007).","journal-title":"Ann. Hematol."},{"key":"BFnrclinonc201040_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","volume":"28","author":"JI Henter","year":"1997","unstructured":"Henter, J. I.  et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH Study Group of the Histiocyte Society. Med. Pediatr. Oncol. 28, 342\u2013347 (1997).","journal-title":"Med. Pediatr. Oncol."},{"key":"BFnrclinonc201040_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/sj.bmt.1705329","volume":"37","author":"M Ostronoff","year":"2006","unstructured":"Ostronoff, M.  et al. Hemophagocytic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma: successful treatment with high-dose intravenous immunoglobulin. Bone Marrow Transplant. 37, 797\u2013798 (2006).","journal-title":"Bone Marrow Transplant."},{"key":"BFnrclinonc201040_CR14","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1542\/peds.2006-3164","volume":"120","author":"N Mahlaoui","year":"2007","unstructured":"Mahlaoui, N.  et al. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients. Pediatrics 120, e622\u2013e628 (2007).","journal-title":"Pediatrics"},{"key":"BFnrclinonc201040_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/pbc.21019","volume":"50","author":"B Makay","year":"2008","unstructured":"Makay, B.  et al. Etanercept for therapy-resistant macrophage activation syndrome. Pediatr. Blood Cancer 50, 419\u2013421 (2008).","journal-title":"Pediatr. Blood Cancer"},{"key":"BFnrclinonc201040_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1365-2567.2009.03115.x","volume":"128","author":"Y Hu","year":"2009","unstructured":"Hu, Y.  et al. Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model. Immunology 128, 260\u2013270 (2009).","journal-title":"Immunology"},{"key":"BFnrclinonc201040_CR17","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1038\/sj.onc.1210380","volume":"26","author":"L Alinari","year":"2007","unstructured":"Alinari, L.  et al. Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia. Oncogene 26, 3644\u20133653 (2007).","journal-title":"Oncogene"},{"key":"BFnrclinonc201040_CR18","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1365-2141.2005.05501.x","volume":"129","author":"A Horne","year":"2005","unstructured":"Horne, A.  et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis. Br. J. Hematol. 129, 622\u2013630 (2005).","journal-title":"Br. J. Hematol."},{"issue":"Suppl. 2","key":"BFnrclinonc201040_CR19","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1038\/bmt.2008.283","volume":"42","author":"N Cooper","year":"2008","unstructured":"Cooper, N.  et al. The use of reduced-intensity stem cell transplantation in hemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis. Bone Marrow Transplant. 42 (Suppl. 2), S47\u2013S50 (2008).","journal-title":"Bone Marrow Transplant."}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2010.40.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2010.40","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2010.40.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:05:44Z","timestamp":1684469144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrclinonc.2010.40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,20]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["BFnrclinonc201040"],"URL":"https:\/\/doi.org\/10.1038\/nrclinonc.2010.40","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,20]]}}}